JD

Joris De Maeyer

Executive in Biotech & VC Industry

Mechelen, Flemish Region

Investor
VC
CEO

Invests in

Stages:

Seed
Pre-seed

Locations:

Antwerp, Belgium

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Lifesciences
Pharmacology
Drug Discovery
Outsourcing
Project Management
Research Funding
Biotechnology
Drug Development
Gastroenterology
Pharmacodynamics
Pharmaceutical Industry
CRO
Translational Research
Pharmacokinetics
R&D
Life Sciences
Research and Development (R&D)

Education

Lists including Joris

AM
AT
AS
AR

All Seed Investors

19695 people

AT
AE
AE
AL

All Pre-Seed Investors

7974 people

Work Experience

BV
Bioqube Ventures

2016

  • Executive in Residence

    2023

  • Investment Director

    2020 - 2023

  • Venture Coach

    2016 - 2020

AT
Anavo Therapeutics BV

2021

  • Board Observer

    2021

Stealth Mode NewCo

2023

  • Founder

    2023

LIFE of SCI

2013

  • Managing Director - Life Science Consulting

    2013

Facio Therapies

2014 - 2022

  • Chief Executive Officer

    2021 - 2022

  • Acting Chief Executive Officer

    2021 - 2021

  • Chief Scientific Officer

    2019 - 2021

  • Director R&D

    2014 - 2019

S
Shire

2011 - 2013

  • Director Discovery

    2011 - 2013

Movetis

2007 - 2010

  • Manager Drug Discovery

    2007 - 2010

J&
Johnson & Johnson

2001 - 2006

  • Research Associate Drug Discovery

    2002 - 2006

  • Senior Associate Quality Assurance Preclinical Research & Development (PKPD TOX)

    2001 - 2002

VM
Vlaamse Milieumaatschappij - VMM

2001 - 2001

  • Auditor Surface Water Monitoring Network

    2001 - 2001

    Temporary assignment.

KL
KU Leuven

2000 - 2001

  • Research associate

    2000 - 2001